Two Medicinal Chemistry Stories: (i) targeting MERTK for imaging in neurodegenerative disease; (ii) anticancer therapeutics targeting KAT6A
发布时间:2024-06-20   访问次数:124

第607次SKLBE学术论坛

报告人:Jonathan Baell, Executive Director of Discovery Chemistry at Lyterian Therapeutics

报告题目:Two Medicinal Chemistry Stories: (i) targeting MERTK for imaging in neurodegenerative disease; (ii) anticancer therapeutics targeting KAT6A

报告时间:2024-6-27(周四)10:00

报告地点:实验18楼315会议室

主持人:张立新教授